AR112840A1 - 3- fenilquinazolin-4(3h)-onas sustituidas y sus usos - Google Patents
3- fenilquinazolin-4(3h)-onas sustituidas y sus usosInfo
- Publication number
- AR112840A1 AR112840A1 ARP180102771A ARP180102771A AR112840A1 AR 112840 A1 AR112840 A1 AR 112840A1 AR P180102771 A ARP180102771 A AR P180102771A AR P180102771 A ARP180102771 A AR P180102771A AR 112840 A1 AR112840 A1 AR 112840A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- optionally substituted
- atom
- fluorine atoms
- hydrogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/91—Oxygen atoms with aryl or aralkyl radicals attached in position 2 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17193995 | 2017-09-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR112840A1 true AR112840A1 (es) | 2019-12-18 |
Family
ID=59997232
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP180102771A AR112840A1 (es) | 2017-09-29 | 2018-09-27 | 3- fenilquinazolin-4(3h)-onas sustituidas y sus usos |
Country Status (4)
| Country | Link |
|---|---|
| AR (1) | AR112840A1 (fr) |
| TW (1) | TW201922724A (fr) |
| UY (1) | UY37907A (fr) |
| WO (1) | WO2019063704A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021167883A1 (fr) * | 2020-02-21 | 2021-08-26 | The Children's Medical Center Corporation | Méthode pour le traitement de l'asthme ou d'une maladie allergique |
| CN112370529B (zh) * | 2020-11-30 | 2022-11-11 | 中国药科大学 | 一种治疗肺动脉高压的复方制剂与制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3966781A (en) | 1970-12-17 | 1976-06-29 | Merck Sharp & Dohme (I.A.) Corporation | Deuteration of functional group-containing hydrocarbons |
| JP4619545B2 (ja) | 1999-03-17 | 2011-01-26 | アストラゼネカ アクチボラグ | アミド誘導体 |
| GB0124627D0 (en) | 2001-10-15 | 2001-12-05 | Smithkline Beecham Plc | Novel compounds |
| AU2003301662A1 (en) | 2002-10-21 | 2004-05-13 | Bristol-Myers Squibb Company | Quinazolinones and derivatives thereof as factor xa inhibitors |
| CN101001845A (zh) * | 2004-06-15 | 2007-07-18 | 阿斯利康(瑞典)有限公司 | 作为抗癌药物的取代喹唑酮 |
| EP2091947A2 (fr) | 2006-12-20 | 2009-08-26 | Takeda San Diego, Inc. | Activateurs de glucokinase |
| EP2675440B1 (fr) | 2011-02-14 | 2020-03-25 | Merck Sharp & Dohme Corp. | Inhibiteurs de cystéine protéases, les cathepsines |
| AU2014234472A1 (en) | 2013-03-20 | 2015-10-29 | Bayer Pharma Aktiengesellschaft | 3-acetylamino-1-(phenyl-heteroaryl-aminocarbonyl or phenyl-heteroaryl-carbonylamino)benzene derivatives for the treatment of hyperproliferative disorders |
| US9682961B2 (en) * | 2013-12-06 | 2017-06-20 | Carna Biosciences, Inc. | Quinazoline derivative |
-
2018
- 2018-09-27 UY UY0001037907A patent/UY37907A/es not_active Application Discontinuation
- 2018-09-27 TW TW107134050A patent/TW201922724A/zh unknown
- 2018-09-27 AR ARP180102771A patent/AR112840A1/es unknown
- 2018-09-27 WO PCT/EP2018/076287 patent/WO2019063704A1/fr active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| TW201922724A (zh) | 2019-06-16 |
| UY37907A (es) | 2019-04-30 |
| WO2019063704A1 (fr) | 2019-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR110922A1 (es) | Compuestos inhibidores del vih | |
| AR093364A1 (es) | Imidazo[1,2-a]piridincarboxamidas aminosustituidas y su uso | |
| AR100438A1 (es) | Pirazolopiridinas y pirazolopirimidinas | |
| AR093580A1 (es) | Inhibidores bmi-1 de pirimidina sustituidos | |
| AR101208A1 (es) | Espirocicloheptanos como inhibidores de rock | |
| AR108356A1 (es) | Derivados aromáticos de sulfonamida | |
| AR093579A1 (es) | Inhibidores de bmi-1 de pirimidina inversa sustituida | |
| AR101189A1 (es) | Heterociclos nitrogenados antiproliferativos y sus métodos de uso | |
| AR100886A1 (es) | 3-amino-1,5,6,7-tetrahidro-4h-indol-4-onas | |
| AR100059A1 (es) | Compuestos útiles como inmunomoduladores | |
| AR110405A1 (es) | Compuestos | |
| AR100702A1 (es) | Compuestos inhibidores de quinasa de unión tank | |
| AR099824A1 (es) | Compuestos bicíclicos | |
| AR099955A1 (es) | Compuestos de heteroarilo o arilo bicíclicos fusionados | |
| AR099228A1 (es) | Inhibidores macrocíclicos de fxia que tienen grupos heterocíclicos | |
| AR107042A1 (es) | Inhibidores de la tirosina quinasa de bruton y métodos de su uso | |
| AR089143A1 (es) | Triazolopiridinas sustituidas con actividad inhibidora de ttk | |
| AR113929A1 (es) | Compuestos heterocíclicos | |
| AR106301A1 (es) | Composiciones de pirrolpirimidina como inhibidores de quinasas | |
| AR097279A1 (es) | Derivados de benzimidazolil-metil urea como agonistas del receptor de alx | |
| AR112840A1 (es) | 3- fenilquinazolin-4(3h)-onas sustituidas y sus usos | |
| AR113346A1 (es) | Derivados de picolinamida microbicidas | |
| AR107041A1 (es) | Inhibidores de la tirosina kinasa de bruton y métodos de su uso | |
| AR113888A1 (es) | Derivados de indol macrocíclicos sustituidos | |
| AR091208A1 (es) | Derivados de piperidina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |